Centessa Pharmaceuticals PLC ADR (CNTA) — Net Asset Momentum
Centessa Pharmaceuticals PLC ADR (CNTA) recorded a net asset momentum of 31.2% as of December 2025, with net assets of $526.86 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See CNTA book value for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Centessa Pharmaceuticals PLC ADR Net Asset Momentum (2019–2025)
This chart tracks Centessa Pharmaceuticals PLC ADR's year-over-year net asset growth across 7 annual reporting periods from 2019 to 2025. The most recent momentum reading is +31.2%, with net assets of $526.86 Million USD as of December 2025. For live market cap and overall valuation, see CNTA company net worth.
Annual Net Asset History for Centessa Pharmaceuticals PLC ADR (2019–2025)
The table below shows the complete annual net asset history for Centessa Pharmaceuticals PLC ADR from 2019 to 2025, covering 7 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check Centessa Pharmaceuticals PLC ADR (CNTA) tangible equity ratio to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $526.86 Million | $687.50 Million | $160.63 Million | ▲ +31.2% |
| 2024 | $401.55 Million | $576.80 Million | $175.25 Million | ▲ +70.0% |
| 2023 | $236.24 Million | $360.25 Million | $124.00 Million | ▼ -29.7% |
| 2022 | $336.17 Million | $444.31 Million | $108.14 Million | ▼ -31.6% |
| 2021 | $491.55 Million | $629.63 Million | $138.08 Million | ▲ +15766.8% |
| 2020 | $3.10 Million | $11.72 Million | $8.62 Million | ▼ -77.3% |
| 2019 | $13.66 Million | $19.73 Million | $6.07 Million | — |